Advancing data analysis tools for proteome-wide cross-linking mass spectrometry (XL-MS) requires ground-truth standards that mimic biological complexity. Here we develop well-controlled XL-MS standards comprising hundreds of recombinant proteins that are systematically mixed for cross-linking. We use one standard dataset to guide the development of Scout, a search engine for XL-MS with MS-cleavable cross-linkers. Using other, independent standard datasets and published datasets, we benchmark the performance of Scout and existing XL-MS software. We find that Scout offers an excellent combination of speed, sensitivity and false discovery rate control. The results illustrate how our large recombinant standard can support the development of XL-MS analysis tools and evaluation of XL-MS results.
Confident deconvolution of proteomic spectra is critical for several applications such as de novo sequencing, cross-linking mass spectrometry and handling chimeric mass spectra. In general, all deconvolution algorithms may eventually report mass peaks that are not compatible with the chemical formula of any peptide. We show how to remove these artifacts by considering their mass defects. We introduce Y.A.D.A. 3.0, a fast deconvolution algorithm that can remove peaks with unacceptable mass defects. Our approach is effective for polypeptides with less than 10 kDa, and its essence can be easily incorporated into any deconvolution algorithm. Y.A.D.A. 3.0 is freely available for academic use at http://patternlabforproteomics.org/yada3. Supplementary information is available at Bioinformatics online.
22 March 2023 in Journal of the American Society for Mass Spectrometry
The Arg87Cys mutation in CYFIP2 has been implicated in early-onset developmental and epileptic encephalopathy (DEE), yet its molecular consequences remain incompletely understood. CYFIP2 functions as part of the WAVE regulatory complex (WRC), where it plays a key role in actin filament polymerization and interacts with RNA-binding proteins (RBPs) to regulate mRNA translation. Previous studies have demonstrated that this mutation alters the structure of CYFIP2, resulting in a gain of function in the WRC. Additionally, the mutation appears to promote the formation of intracellular granules that colocalize with RBPs; however, the impacts of this mutation on these interactions remain unclear. Here, we combined cross-linking mass spectrometry (XL-MS) and label-free quantitative proteomics to investigate how this mutation alters the protein interactome and actin regulatory pathways. XL-MS data revealed exclusive cross-links between actin and tropomyosin isoforms in the Arg87Cys variant, suggesting altered cytoskeletal dynamics. Quantitative proteomic analysis of patient-derived neural progenitor cells corroborated these findings by revealing an increase in the abundance of stress-fiber-associated proteins. Altogether, our results point to a broader impact of CYFIP2 mutations on cytoskeletal organization and protein interaction networks with potential implications beyond the nervous system. This is the first study to our knowledge to suggest a link between the Arg87Cys mutation and dysregulation of stress-fiber-related proteins, indicating possible disruption of other actin-processing pathways.